Click to close

Contact us

Please complete the required fields.

*Required Fields

Click to close

Request a Demo

Please complete the required fields.

*Required Fields

Request a Demo
Click to close

Report Problem

Please complete the required fields.

*Required Fields



Click to close

Please complete the required fields.

Forgot your password? Register

Tell us your email address and we'll send you instructions on how to reset your password.

Click to close

Resolution not supported

Click to close



GBECAM was founded on March 11th 2005 by a team of Brazilian oncologists who shared a profound interest and commitment in the studies of breast cancer.

GBECAM is a non-profit and independent organization whose main objective is to implement and promote quality and ethical multi-institutional clinical trials on breast cancer in Brazil, as well as to implement and offer aid to clarifying and preventing educational programs about breast cancer.

At present, GBECAM brings together 60 members (oncologists and breast surgeons). These members work as researchers and implement the group projects in their respective institutions (such as hospitals, universities and specialized clinics). GBECAM intends to integrate the entire country for the development of breast cancer clinical research and for that reason it has been affiliating, as its members, investigators who possess highly developed scientific and ethical abilities.

The clinical trials conducted by GBECAM are previously selected to fulfill the needs of those carrying breast cancers and only then are they distributed among the affiliated institutions and investigators throughout the country.

The studies are prepared and developed in partnership with the research and development areas of the pharmaceutical industry, international cooperative groups, such as BIG (Breast international Group), CIBOMA (Coalicion Iberoamericana De Investigacion En Oncología Mamaria) and by GBECAM itself through its members and scientific commission.

Website   Found your center? Register here

Research Activity

  • Trials at Site-level (All): 92   
  • Trials at Site-level (Phase I): N/A   
  • Trials at Site-level (Phase II): 15   
  • Trials at Site-level (Phase III): 77   
  • Trials at Site-level (Phase IV): N/A   
  • Trials at Site-level (Ongoing): 55   

Research Infrastructure

  • Diseases Studied: 170   
  • Trials per Center: 4   

Research Personnel

  • Investigators: 9   

Patient Population

  • Available Patients: 152,666   
  • Enrolled Patients: 2,519   
  • Engagement Level: 0.04   

Please select a disease

  • Adult Cognitive Disorder
  • Arrhythmia
  • Breast Cancer
  • Cerebrovascular Disorder
  • CNS Infection
  • Colorectal Cancer
  • Diabetes
  • Dyslipidemia
  • Hematologic Cancer
  • HIV Infection
  • Hypertension
  • Influenza
  • Ischemic Heart Disease
  • Lung Cancer
  • Mood Disorder
  • Movement Disorder
  • Pneumonia
  • Prostate Cancer
  • Schizophrenia
  • Seizure Disorder
  • Viral Hepatitis

Map description: Available Patients by Enrolled Patients The following map displays ViS' patient population metrics for the GBECAM network. The bubble size indicates level of Enrolled Patients calculated at the zip code level for each research center and the color indicates level of Available Patients calculated at the city level

Research Centers (45)